Evidence map›Paper›PMID 42245339›Full record

ReviewFrontiers in public health2026

Potential side effects of toxic and restricted substances found in cosmetics declared to be of natural origin.

Dorottya Koncz, Monika Anne Nemeth, Edina Pallagi, Barbara Tóth, Dezso Csupor

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dorottya KonczInstitute of Clinical Pharmacy, University of Szeged, Szeged, Hungary.
Monika Anne NemethInstitute of Clinical Pharmacy, University of Szeged, Szeged, Hungary.
Edina PallagiInstitute of Clinical Pharmacy, University of Szeged, Szeged, Hungary.
Barbara TóthInstitute of Clinical Pharmacy, University of Szeged, Szeged, Hungary.
Dezso CsuporInstitute of Clinical Pharmacy, University of Szeged, Szeged, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cosmetic products are an integral part of daily life. However, although the regulatory framework for such products appears strict, customer safety and product quality are not guaranteed. A large proportion of consumers prefer using cosmetic products that contain natural substances to avoid exposure of their skin to chemicals. Nevertheless, some of the products marketed to meet this need are not natural or even safe. Methods: This article presents an overview of reports on cosmetic products declared to be of natural origin in the European Union Safety Gate system between 2005 and 2023. Results: Many reported cosmetic products posed a chemical risk by containing unauthorized substances (64%) or exceedance of authorized limits (14%). Butylphenyl methylpropional (also known as lilial) was the dominant ingredient present in several product categories. Microbial contamination was also detected (12%), but at a markedly lower rate compared to that recorded for the presence of chemicals (79%). Conclusion: Use of the term "natural" to describe cosmetic products can be misleading because it does not always comply with the criteria for natural and organic cosmetic components. Importantly, such cosmetic products could pose a serious risk to consumers due to hidden unsafe substances. Hence, implementation of appropriate measures is necessary to ensure consumer safety.

Indexed as

Biological ProductsConsumer Product SafetyCosmeticsEuropean UnionHumansBiological ProductsCosmeticsBMHCAcosmetovigilanceEU safety gategreenwashingnatural cosmetics

Identifiers

PMID42245339
PMCPMC13230110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.